<< [Back to News Releases]

CareFusion Launches New AVAflex® Vertebral Balloon System for Targeted Balloon Placement

Also Introduces the pink Achieve® Breast Biopsy Device

Mar 24, 2014

SAN DIEGO, March 24, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, launched its new AVAflex® Vertebral Balloon System today at the 39th annual Scientific Meeting of the Society of Interventional Radiology (SIR).

The new system is the latest innovation in CareFusion’s AVAmax® Advanced Vertebral Augmentation portfolio. The focus of these products is to provide a minimally invasive solution to treat vertebral compression fractures, while also promoting safety for the patient, physician and staff. The AVAflex Vertebral Balloon System combines the unique features of the AVAflex Curved Vertebral Augmentation Needle and the AVAmax Vertebral Balloon to enable targeted balloon placement across the midline of the vertebral body, followed by targeted cement placement for optimal fill through a single pedicle.

“Our new AVAflex Vertebral Balloon System has a curved needle and balloon, featuring a flexible tip that is designed to target balloon placement and ultimately target cement placement,” said Michael Voss, senior vice president and general manager of Interventional Specialties for CareFusion. “The system also has the ability to create multiple cavities through a single insertion site, which can help minimize patient trauma.”

The new AVAflex Vertebral Balloon System is available in 15mm and 20mm balloon sizes, with a 30mm option to be launched in the coming months.

Additional CareFusion technologies and products debuting at SIR include:

  • The pink Achieve® biopsy device: A lightweight, one-handed design with delayed firing option for visualization of needle placement in lesion for precise breast biopsy samples. The new device features echogenic markings to support precise ultrasound positioning and is spring loaded for fast, accurate tissue penetration. The pink Achieve biopsy device also comes with an optional coaxial introducer for multiple sampling.
  • Safe-T PLUS lumbar puncture and myelogram tray: Features atraumatic BD Whitacre needles that are proven to reduce post-lumbar puncture headaches in lumbar puncture and myelogram patients[1] through a pencil-point configuration that spreads dura fibers, helping minimize cerebrospinal fluid loss. The BD Whitacre needle provides precise access and control, and clear visualization of cerebrospinal fluid.


CareFusion will be exhibiting these new technologies at the SIR Scientific Meeting in booth 409.


 About CareFusion Corporation
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps and IV sets, MaxPlus® and MaxZero™ IV connectors and sets, Pyxis® automated dispensing and patient identification systems, AVEA®, LTV® series and AirLife® ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs approximately 15,000 people across its global operations. More information may be found at www.carefusion.com.


[1] Arendt, K., Demaerschalk, D., Wingerchuk, M. et al. “Atraumatic lumbar puncture needles: After all these years, are we still missing the point?” Neurologist, January 2009,15(1):17–20.

For further information: Media, Troy Kirkpatrick, (858) 617-2361, troy.kirkpatrick@carefusion.com, or Investors, Jim Mazzola, (858) 617-1203, jim.mazzola@carefusion.com